Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dienstbier

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Nucleic Acids Research|July 8, 2025
Global analysis of the Hfq-mediated RNA interactome discovers a MicA homolog that affects the cytotoxicity, biofilm formation, and resistance to complement of Bordetella pertussisDilip Kumar, Martin Beles, Argha Saha, et al.
Msystems|December 9, 2020
A Mutation Upstream of the <i>rplN-rpsD</i> Ribosomal Operon Downregulates Bordetella pertussis Virulence Factor Production without Compromising Bacterial Survival within Human MacrophagesJakub Novák, David Jurnečka, Irena Linhartová, et al.
Emerging Infectious Diseases|December 22, 2020
Comparative Omics Analysis of Historic and Recent Isolates of Bordetella pertussis and Effects of Genome Rearrangements on EvolutionAna Dienstbier, Fabian Amman, Denisa Petráčková, et al.
The International Journal of Biological Markers|September 1, 1986
The joint Task Group on clinical utility of labelled antibodies of the Society of Nuclear Medicine Europa (SNME) and the European Nuclear Medicine Society (ENMS)G Buraggi, K E Britton, U Büll, et al.
Cell Reports|May 27, 2014
Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitmentSarah Cooper, Martin Dienstbier, Raihann Hassan, et al.
Annals of the Rheumatic Diseases|April 14, 2022
Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritisVanessa Waltereit-Kracke, Corinna Wehmeyer, Denise Beckmann, et al.
Journal of Medicinal Chemistry|December 6, 2022
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic ActivityLaura Sinatra, Jing Yang, Julian Schliehe-Diecks, et al.
Frontiers in Immunology|December 24, 2024
Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture systemChristina Völzke, Lisa Ehrhardt, Laura Fischer, et al.
Cell Death & Disease|December 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cellsCéline David, Yadong Sun, Vitalij Woloschin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Nucleic Acids Research|July 8, 2025
Global analysis of the Hfq-mediated RNA interactome discovers a MicA homolog that affects the cytotoxicity, biofilm formation, and resistance to complement of Bordetella pertussisDilip Kumar, Martin Beles, Argha Saha, et al.
Msystems|December 9, 2020
A Mutation Upstream of the <i>rplN-rpsD</i> Ribosomal Operon Downregulates Bordetella pertussis Virulence Factor Production without Compromising Bacterial Survival within Human MacrophagesJakub Novák, David Jurnečka, Irena Linhartová, et al.
Emerging Infectious Diseases|December 22, 2020
Comparative Omics Analysis of Historic and Recent Isolates of Bordetella pertussis and Effects of Genome Rearrangements on EvolutionAna Dienstbier, Fabian Amman, Denisa Petráčková, et al.
The International Journal of Biological Markers|September 1, 1986
The joint Task Group on clinical utility of labelled antibodies of the Society of Nuclear Medicine Europa (SNME) and the European Nuclear Medicine Society (ENMS)G Buraggi, K E Britton, U Büll, et al.
Cell Reports|May 27, 2014
Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitmentSarah Cooper, Martin Dienstbier, Raihann Hassan, et al.
Annals of the Rheumatic Diseases|April 14, 2022
Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritisVanessa Waltereit-Kracke, Corinna Wehmeyer, Denise Beckmann, et al.
Journal of Medicinal Chemistry|December 6, 2022
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic ActivityLaura Sinatra, Jing Yang, Julian Schliehe-Diecks, et al.
Frontiers in Immunology|December 24, 2024
Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture systemChristina Völzke, Lisa Ehrhardt, Laura Fischer, et al.
Cell Death & Disease|December 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cellsCéline David, Yadong Sun, Vitalij Woloschin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Pageof 27